What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
The scientist’s investigation covers issues in Microvesicles, Virology, Cell biology, Bovine spongiform encephalopathy and Scrapie.
His Microvesicles research focuses on Exosome in particular.
His Virology study integrates concerns from other disciplines, such as Phenotype, Transmissible spongiform encephalopathy, In vivo and Antiretroviral therapy.
The study incorporates disciplines such as Secretion, Extracellular vesicle, Alpha-synuclein and Amyloid precursor protein in addition to Cell biology.
He has included themes like Tonsil, Immunology, Creutzfeldt-Jakob Syndrome and Biopsy in his Bovine spongiform encephalopathy study.
His research in Scrapie intersects with topics in Infectivity, Proteinase K and Hamster.
His most cited work include:
- Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines (2148 citations)
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma (1975 citations)
- Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD (1516 citations)
What are the main themes of his work throughout his whole career to date?
Andrew F. Hill mainly focuses on Cell biology, Virology, Microvesicles, Internal medicine and Biochemistry.
His Cell biology study combines topics in areas such as Biogenesis, Alpha-synuclein and Amyloid precursor protein.
Andrew F. Hill has researched Virology in several fields, including Scrapie, PrPSc Proteins, Transmissible spongiform encephalopathy, Bovine spongiform encephalopathy and Disease.
His Bovine spongiform encephalopathy study focuses on Transmissible mink encephalopathy in particular.
His Microvesicles research incorporates themes from RNA and Extracellular vesicles.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology, Oncology and Emtricitabine.
He most often published in these fields:
- Cell biology (25.93%)
- Virology (22.45%)
- Microvesicles (22.45%)
What were the highlights of his more recent work (between 2018-2021)?
- Cell biology (25.93%)
- Microvesicles (22.45%)
- Internal medicine (14.58%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cell biology, Microvesicles, Internal medicine, Extracellular vesicles and Disease.
His Cell biology research is multidisciplinary, incorporating elements of Small RNA, Neurodegeneration and Amyloid precursor protein.
His Microvesicles research is multidisciplinary, incorporating perspectives in Pathogenesis, Sphingolipid, Proteomics, Parkinson's disease and Mesenchymal stem cell.
His research in the fields of Prospective cohort study overlaps with other disciplines such as Ipilimumab.
His work focuses on many connections between Extracellular vesicles and other disciplines, such as Computational biology, that overlap with his field of interest in Nanoparticle, Heterogeneous population, In vivo, In vitro and Cellular origin.
His research integrates issues of Genotype, microRNA, Function and Brain tissue in his study of Disease.
Between 2018 and 2021, his most popular works were:
- Five-year survival with combined nivolumab and ipilimumab in advanced melanoma: New England Journal of Medicine (594 citations)
- Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV (159 citations)
- Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission (148 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His primary areas of investigation include Microvesicles, Extracellular vesicles, Internal medicine, Neuroscience and microRNA.
His study in Microvesicles is interdisciplinary in nature, drawing from both Small RNA, Proteomics, Disease and Cell biology.
He studies Cell biology, namely Endosome.
His study on Intention-to-treat analysis, Phases of clinical research and Odds ratio is often connected to Ipilimumab as part of broader study in Internal medicine.
The various areas that Andrew F. Hill examines in his Neuroscience study include Lewy body, Neurotoxicity, Alpha-synuclein and Amyloid.
He interconnects Biomarker, Transgene, Disease biomarker and Pathogenesis in the investigation of issues within microRNA.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
